Discover 1,912 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,912
Exploring Virtual Reality Adventure Training Exergaming
Reducing Blood Pressure in Mid-life Adult Binge Drinkers
for
Alcohol Drinking, Binge Drinking, Blood Pressure,
Location: Arlington TX
Sponsor: The University of Texas at Arlington
Sex: All
Age: 50 - 64
Code: NCT05522075
Recruiting
Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes
for
Adult ALL
Location: Arlington TX
Sponsor: The University of Texas at Arlington
Sex: All
Age: 18 - 70+
Code: NCT06727942
Recruiting
Using Near-Infrared Light to Better Understand Peripheral Artery Disease
for
Peripheral Artery Disease (PAD)
Location: Arlington TX
Sponsor: The University of Texas at Arlington
Sex: All
Age: 18+
Code: NCT07313410
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
Hormone-free Antral Retrieval for Viable Embryo Storage & Transfer
for
Infertility
Location: Bedford TX
Sponsor: Kevin Doody
Sex: Female
Age: 18 - 35
Code: NCT07801105
Recruiting
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
for
Infertility (IVF Patients)
Location: Bedford TX, Webster TX, Atlanta GA, Chicago IL,
Sponsor: Granata Bio Corporation
Sex: Female
Age: 18 - 42
Code: NCT07216742
Phase3, Recruiting
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Location: Arlington TX, Houston TX, Little Rock AR, Wichita KS,
Sponsor: Valencia Technologies Corporation
Sex: All
Age: 18+
Code: NCT05685433
Recruiting
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer
Location: Arlington TX, Austin TX, San Antonio TX, Houston TX,
Sponsor: Protara Therapeutics
Sex: All
Age: 18+
Code: NCT05951179
Phase2, Recruiting
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
for
Overactive Bladder, Urinary Urgency Incontinence,
Location: Arlington TX, Shreveport LA, Tulsa OK, New Orleans LA,
Sponsor: Axonics, Inc.
Sex: Male
Age: 18+
Code: NCT06511141
Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Arlington TX, Dallas TX, Austin TX, San Antonio TX,
Sponsor: CG Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06567743
Phase2, Recruiting
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
for
Non-Muscle Invasive Bladder Neoplasms
Location: Arlington TX, Little Rock AR, St Louis MO,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07309445
Recruiting
Ambulatory Long Length URodynamics Evaluation
for
Urology, Urinary Bladder, Overactive,
Location: Arlington TX, St Louis MO, Sioux Falls SD,
Sponsor: Bright Uro
Sex: All
Age: 22+
Code: NCT07425015
Recruiting
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
for
Bladder (Urothelial, Transitional Cell) Cancer,
Location: Arlington TX, Houston TX, Little Rock AR, St Louis MO,
Sponsor: Protara Therapeutics
Sex: All
Age: 18+
Code: NCT07480356
Phase3, Recruiting
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer